125 related articles for article (PubMed ID: 9518043)
1. Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis.
Gemmati D; Serino ML; Verzola I; Mari R; Moratelli S; Ballerini G
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):118-23. PubMed ID: 9518043
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of hereditary thrombophilia.
Michiels JJ; Hamulyák K
Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
[TBL] [Abstract][Full Text] [Related]
3. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk.
Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670
[TBL] [Abstract][Full Text] [Related]
4. Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program.
Jennings I; Kitchen S; Woods TA; Preston FE
Semin Thromb Hemost; 2005 Feb; 31(1):66-72. PubMed ID: 15706477
[TBL] [Abstract][Full Text] [Related]
5. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
Delahousse B; Iochmann S; Pouplard C; Fimbel B; Charbonnier B; Gruel Y
Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
[TBL] [Abstract][Full Text] [Related]
6. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
7. A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype.
Gemmati D; Serino ML; Scapoli GL
Thromb Res; 1998 Nov; 92(3):141-8. PubMed ID: 9806366
[TBL] [Abstract][Full Text] [Related]
8. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
De Stefano V; Leone G
Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
[TBL] [Abstract][Full Text] [Related]
9. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
[TBL] [Abstract][Full Text] [Related]
10. [Congenital protein S deficiencies; diagnostic difficulties].
Guermazi S; Conard J
Pathol Biol (Paris); 2009 Sep; 57(6):483-7. PubMed ID: 18583066
[TBL] [Abstract][Full Text] [Related]
11. Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin.
Andresen MS; Iversen N; Abildgaard U
Thromb Res; 2002 Dec; 108(5-6):323-8. PubMed ID: 12676193
[TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
13. Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories.
Smock KJ; Plumhoff EA; Meijer P; Hsu P; Zantek ND; Heikal NM; Van Cott EM
Thromb Haemost; 2016 Jul; 116(1):50-7. PubMed ID: 27075008
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic correction of activated protein C resistance following orthotopic liver transplantation.
Foster PA; Varma RR
Blood Coagul Fibrinolysis; 1996 Jan; 7(1):65-8. PubMed ID: 8845465
[TBL] [Abstract][Full Text] [Related]
15. Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C.
Kraus M; Zander N; Fickenscher K
Thromb Res; 1995 Nov; 80(3):255-64. PubMed ID: 8578552
[TBL] [Abstract][Full Text] [Related]
16. Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.
Ichiyama M; Ohga S; Ochiai M; Tanaka K; Matsunaga Y; Kusuda T; Inoue H; Ishimura M; Takimoto T; Koga Y; Hotta T; Kang D; Hara T
Pediatr Res; 2016 Jan; 79(1-1):81-6. PubMed ID: 26372516
[TBL] [Abstract][Full Text] [Related]
17. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors.
Giri TK; Yamazaki T; Sala N; Dahlbäck B; de Frutos PG
Blood; 2000 Jul; 96(2):523-31. PubMed ID: 10887114
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2.
Lambropoulos AF; Foka Z; Makris M; Daly M; Kotsis A; Makris PE
Blood Coagul Fibrinolysis; 1997 Nov; 8(8):485-9. PubMed ID: 9491265
[TBL] [Abstract][Full Text] [Related]
19. [Screening methods in genetic diagnosis of hereditary protein C deficiency].
Dávid M; Losonczy H; Nagy A; Kutscher G; Meyer M
Orv Hetil; 1999 Jan; 140(3):125-32. PubMed ID: 9990817
[TBL] [Abstract][Full Text] [Related]
20. Protein S.
Hepner M; Karlaftis V
Methods Mol Biol; 2013; 992():373-81. PubMed ID: 23546730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
